Adherence to subcutaneous interferon beta-1a treatment using an electronic injection device: a prospective open-label Scandinavian noninterventional study (the ScanSmart study)

Autor: Nils Meland, Egon Stenager, Roman Schmid, Jette L. Frederiksen, Gry Irene Magnussen, J. L. Vadgaard, Elena Pedersen, Michael Broksgaard Jensen

Publikováno v: Patient preference and adherence
Pedersen, E D, Stenager, E, Vadgaard, J L, Jensen, M B, Schmid, R, Meland, N, Magnussen, G & Frederiksen, J L 2018, ' Adherence to subcutaneous interferon beta-1a treatment using an electronic injection device : a prospective open-label Scandinavian noninterventional study (the ScanSmart study) ', Patient Preference and Adherence, vol. 12, pp. 569-575 . https://doi.org/10.2147/PPA.S154417
Pedersen, E D, Stenager, E, Vadgaard, J L, Jensen, M B, Schmid, R, Meland, N, Magnussen, G & frederiksen, J L 2018, ' Adherence to subcutaneous interferon beta-1a treatment using an electronic injection device : a prospective open-label scandinavian noninterventional study (The scansmart study) ', Patient Preference and Adherence, vol. 12, pp. 569-575 . https://doi.org/10.2147/PPA.S154417
Patient Preference and Adherence, Vol Volume 12, Pp 569-575 (2018)

Elena Didenko Pedersen,1,2 Egon Stenager,3,4 JL Vadgaard,5 MB Jensen,6 R Schmid,7 N Meland,8 G Magnussen,9 Jette L Frederiksen10,11 1Akershus University Hospital, Department of Neurology, Loerenskog, Norway; 2Sandvika Nevrosenter, Sandvika, Norway; 3

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a2a73a3ca5cb81e2fe18666fa13400b
https://doi.org/10.2147/ppa.s154417